Daniel G. Stover

11.8k total citations · 1 hit paper
148 papers, 3.1k citations indexed

About

Daniel G. Stover is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Daniel G. Stover has authored 148 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Oncology, 67 papers in Cancer Research and 47 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Daniel G. Stover's work include Breast Cancer Treatment Studies (38 papers), Cancer Genomics and Diagnostics (29 papers) and Advanced Breast Cancer Therapies (26 papers). Daniel G. Stover is often cited by papers focused on Breast Cancer Treatment Studies (38 papers), Cancer Genomics and Diagnostics (29 papers) and Advanced Breast Cancer Therapies (26 papers). Daniel G. Stover collaborates with scholars based in United States, Canada and Australia. Daniel G. Stover's co-authors include Brian Bierie, Harold L. Moses, Eric P. Winer, Laura M. Selfors, Joan S. Brugge, Maryam B. Lustberg, Chan-Sup Shim, Anna Chytil, Mary Aakre and Zuzana Keckesova and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Daniel G. Stover

129 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CDK7-Dependent Transcriptional Addiction in Triple-Negative Breast Cancer

2015 347 citations Daniel G. Stover et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel G. Stover United States	26	1.5k	1.3k	783	658	373	148	3.1k
Yuan Yuan United States	30	1.7k 1.1×	1.5k 1.2×	1.2k 1.5×	735 1.1×	425 1.1×	168	3.6k
Shengrong Sun China	28	1.0k 0.7×	1.2k 1.0×	842 1.1×	421 0.6×	356 1.0×	128	2.9k
Sun‐Young Kong South Korea	32	1.3k 0.9×	1.4k 1.1×	683 0.9×	498 0.8×	373 1.0×	204	3.7k
Saranya Chumsri United States	31	2.1k 1.4×	1.3k 1.0×	1.0k 1.3×	588 0.9×	628 1.7×	125	3.8k
Bríd M. Ryan United States	27	1.1k 0.7×	2.3k 1.8×	1.4k 1.8×	495 0.8×	381 1.0×	80	3.7k
Yongmei Yin China	32	1.3k 0.9×	1.7k 1.4×	1.2k 1.5×	680 1.0×	470 1.3×	200	3.5k
Jessica Wang‐Rodriguez United States	34	959 0.7×	2.0k 1.6×	894 1.1×	634 1.0×	284 0.8×	96	3.9k
Deborah Dillon United States	32	1.5k 1.1×	1.5k 1.1×	829 1.1×	473 0.7×	361 1.0×	87	3.7k
José Alejandro Pérez Fidalgo Spain	27	1.4k 1.0×	1.3k 1.0×	853 1.1×	569 0.9×	194 0.5×	136	2.9k
Toru Kumagai Japan	32	1.4k 1.0×	1.1k 0.8×	741 0.9×	1.4k 2.1×	288 0.8×	156	3.1k

Countries citing papers authored by Daniel G. Stover

Since Specialization

Citations

This map shows the geographic impact of Daniel G. Stover's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel G. Stover with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel G. Stover more than expected).

Fields of papers citing papers by Daniel G. Stover

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel G. Stover. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel G. Stover. The network helps show where Daniel G. Stover may publish in the future.

Co-authorship network of co-authors of Daniel G. Stover

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel G. Stover. A scholar is included among the top collaborators of Daniel G. Stover based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel G. Stover. Daniel G. Stover is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Peng, Cheng, Yuxi Liu, Yujing J. Heng, et al.. (2025). The impact of reproductive factors on breast tumor and normal-adjacent tissue immune profile from menarche to menopause. Carcinogenesis. 46(2).

Azam, Shadi, Saurabh Deepak Chitnis, Katharine A. Collier, et al.. (2024). Association between Inflammatory Dietary Pattern and Mammographic Features. Journal of Nutrition. 154(11). 3437–3445. 1 indexed citations

Loman, Brett R., Sagar Sardesai, Nicole Williams, et al.. (2024). Baseline gut microbiome alpha diversity predicts chemotherapy-induced gastrointestinal symptoms in patients with breast cancer. npj Breast Cancer. 10(1). 99–99. 2 indexed citations

Toland, Amanda Ewart, Carolyn J. Presley, Heather L. Hampel, et al.. (2024). A video intervention to improve patient understanding of tumor genomic testing in patients with cancer. Cancer Medicine. 13(17). e70095–e70095.

Liu, Yaping, Sarah C. Reed, Christopher Lo, et al.. (2024). FinaleMe: Predicting DNA methylation by the fragmentation patterns of plasma cell-free DNA. Nature Communications. 15(1). 2790–2790. 12 indexed citations

Damodaran, Senthil, Massimo Cristofanilli, Matthew P. Goetz, et al.. (2024). Abstract PO2-14-09: Baseline genomic alterations and the activity of lasofoxifene (LAS) plus abemaciclib (Abema) in patients with ER+/HER2- metastatic breast cancer (mBC): the ELAINE 2 study. Cancer Research. 84(9_Supplement). PO2–14. 1 indexed citations

Raghavendra, Akshara Singareeka, Qingchun Jin, Melissa Grimm, et al.. (2024). Clinical outcomes of early-stage triple-negative breast cancer after neoadjuvant chemotherapy according to HER2-low status☆. ESMO Open. 9(11). 103973–103973. 4 indexed citations

Tinoco, Gabriel, Junko Tsuji, Dwight H. Owen, et al.. (2024). Assay Validation of Cell-Free DNA Shallow Whole-Genome Sequencing to Determine Tumor Fraction in Advanced Cancers. Journal of Molecular Diagnostics. 26(5). 413–422. 10 indexed citations

Goldstein, Daniel A., Dionisia Quiroga, Mahmoud Kassem, et al.. (2023). The Immunomodulatory Effects of Dexamethasone on Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer. Oncology and Therapy. 11(3). 361–374. 1 indexed citations

10.

Bárcenas, Carlos H., Richard J. Bleicher, Adam L. Cohen, et al.. (2023). Clinicopathologic and sociodemographic factors associated with late relapse triple negative breast cancer in a multivariable logistic model: A multi-institution cohort study. The Breast. 67. 89–93.

11.

Madison, Annelise A., Megan E. Renna, Rebecca Andridge, et al.. (2023). Conflicts hurt: social stress predicts elevated pain and sadness after mild inflammatory increases. Pain. 164(9). 1985–1994. 5 indexed citations

12.

Sella, Tal, Geoffrey Fell, Peter G. Miller, et al.. (2022). Patient perspectives on testing for clonal hematopoiesis of indeterminate potential. Blood Advances. 6(24). 6151–6161. 8 indexed citations

13.

Thompson, Kevin J., Roberto A. Leon‐Ferre, Jason P. Sinnwell, et al.. (2022). Luminal androgen receptor breast cancer subtype and investigation of the microenvironment and neoadjuvant chemotherapy response. NAR Cancer. 4(2). zcac018–zcac018. 26 indexed citations

14.

Symmans, W. Fraser, Yujia Wen, Charles M. Perou, et al.. (2022). Challenges and Gaps in Clinical Trial Genomic Data Management. JCO Clinical Cancer Informatics. 6(6). e2100193–e2100193. 2 indexed citations

15.

Abdel‐Rahman, Mohamed H., Alireza Asadpoure, Colleen M. Cebulla, et al.. (2021). A Mathematical Model of Breast Tumor Progression Based on Immune Infiltration. Journal of Personalized Medicine. 11(10). 1031–1031. 23 indexed citations

16.

Li, Jin, Xue Wu, Zhi Jiang Zeng, et al.. (2020). Essentiality and Transcriptome-Enriched Pathway Scores Predict Drug-Combination Synergy. Biology. 9(9). 278–278. 11 indexed citations

17.

Sceneay, Jaclyn, Kristin Wilson, Sara Morrow, et al.. (2019). Interferon Signaling Is Diminished with Age and Is Associated with Immune Checkpoint Blockade Efficacy in Triple-Negative Breast Cancer. Cancer Discovery. 9(9). 1208–1227. 110 indexed citations

18.

Wang, Limei, Jin Li, Garrett Kinnebrew, et al.. (2019). Identification of Alternatively-Activated Pathways between Primary Breast Cancer and Liver Metastatic Cancer Using Microarray Data. Genes. 10(10). 753–753. 11 indexed citations

19.

Bierie, Brian, Sarah E. Pierce, Daniel G. Stover, et al.. (2017). Integrin-β4 identifies cancer stem cell-enriched populations of partially mesenchymal carcinoma cells. Proceedings of the National Academy of Sciences. 114(12). E2337–E2346. 244 indexed citations

20.

Bierie, Brian, Daniel G. Stover, Ty W. Abel, et al.. (2008). Transforming Growth Factor–β Regulates Mammary Carcinoma Cell Survival and Interaction with the Adjacent Microenvironment. Cancer Research. 68(6). 1809–1819. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact